Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRUX
Columbia Core Bond ETF
CRUX
|
+$707M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$684M |
| 3 |
Micron Technology
MU
|
+$655M |
| 4 |
EOG Resources
EOG
|
+$556M |
| 5 |
Broadcom
AVGO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.1B |
| 2 |
Visa
V
|
+$870M |
| 3 |
Bloom Energy
BE
|
+$845M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 5 |
Microsoft
MSFT
|
+$723M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.89% |
| 2 | Financials | 10.23% |
| 3 | Industrials | 8.46% |
| 4 | Healthcare | 7.99% |
| 5 | Consumer Discretionary | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
iShares iBonds Dec 2029 Term Treasury ETF
IBTJ
$1.31B
| $21.7M | 0.01% |
994,258
+784,955
| +375% | +$17.2M |
|
1352
Celanese
CE
$5.09B
| $21.6M | 0.01% |
328,987
+91,065
| +38% | +$4.76M |
|
1353
Xtrackers Russell US Multifactor ETF
DEUS
$299M
| $21.6M | 0.01% |
361,076
-123,230
| -25% | -$7.52M |
|
1354
CDW
CDW
$17.1B
| $21.6M | 0.01% |
178,361
+26,374
| +17% | +$3.33M |
|
1355
Gulfport Energy Corp
GPOR
$2.83B
| $21.6M | 0.01% |
101,944
-353
| -0.3% | -$70.2K |
|
1356
iShares Global Infrastructure ETF
IGF
$11B
| $21.5M | 0.01% |
321,496
+80,910
| +34% | +$5.31M |
|
1357
iShares Global REIT ETF
REET
$5.12B
| $21.5M | 0.01% |
855,851
+826,590
| +2,825% | +$21.5M |
|
1358
Valmont Industries
VMI
$9.44B
| $21.5M | 0.01% |
53,740
-19,837
| -27% | -$8.66M |
|
|
PCG.PRX
1359
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.4B
| $21.4M | 0.01% |
495,000
| – | – |
|
|
NEE.PRV
1360
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
| $21.2M | ﹤0.01% |
+422,950
| New | +$21.1M |
|
1361
DoubleVerify
DV
$1.62B
| $21.2M | ﹤0.01% |
2,230,185
+251,783
| +13% | +$2.57M |
|
1362
Kura Sushi USA
KRUS
$537M
| $21.2M | ﹤0.01% |
303,270
+5,942
| +2% | +$399K |
|
1363
Alcoa
AA
$11.7B
| $21.1M | ﹤0.01% |
318,657
-13,166
| -4% | -$808K |
|
1364
Boston Beer
SAM
$1.88B
| $21.1M | ﹤0.01% |
91,529
+626
| +0.7% | +$141K |
|
1365
CG Oncology
CGON
$6.11B
| $21.1M | ﹤0.01% |
311,523
+71,046
| +30% | +$4.03M |
|
1366
Scotiabank
BNS
$106B
| $21.1M | ﹤0.01% |
290,379
+16,087
| +6% | +$1.18M |
|
|
EFOR
1367
Everforth Inc
EFOR
$845M
| $21.1M | ﹤0.01% |
544,538
+83,110
| +18% | +$3.7M |
|
1368
Darling Ingredients
DAR
$9.93B
| $21.1M | ﹤0.01% |
340,764
+183,274
| +116% | +$9.03M |
|
1369
Gentex
GNTX
$4.88B
| $21.1M | ﹤0.01% |
964,126
-215,282
| -18% | -$4.99M |
|
1370
GSK
GSK
$103B
| $21.1M | ﹤0.01% |
381,099
+80,716
| +27% | +$4.37M |
|
1371
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.58B
| $20.9M | ﹤0.01% |
1,065,504
-72,997
| -6% | -$1.44M |
|
1372
Astera Labs
ALAB
$50B
| $20.9M | ﹤0.01% |
190,620
-28,087
| -13% | -$4M |
|
1373
Willdan Group
WLDN
$1.1B
| $20.9M | ﹤0.01% |
272,354
+92,456
| +51% | +$9.78M |
|
1374
Warner Bros
WBD
$64.6B
| $20.8M | ﹤0.01% |
758,396
+21,138
| +3% | +$592K |
|
1375
ANI Pharmaceuticals
ANIP
$1.77B
| $20.8M | ﹤0.01% |
270,262
+359
| +0.1% | +$28K |
|
Similar funds
Ameriprise's Q1 2026 Portfolio in Review
As of Q1 2026, Ameriprise held 4,261 positions worth $432B, down 2.4% from $443B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q1 2026 filing shows 190 new, 1,715 increased, 2,050 reduced and 216 closed positions. Its largest new stake was Columbia Core Bond ETF: 23,603,545 shares worth $709M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.1B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q1 2026 buy was Columbia Core Bond ETF: 23,603,545 shares worth $709M.
- Ameriprise added most to Berkshire Hathaway Class B in Q1 2026, an estimated $684M increase.
- Ameriprise's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.1B.
- Ameriprise fully exited Exact Sciences in Q1 2026, selling an estimated $174M.
- Ameriprise's ten largest holdings make up 19% of its $432B portfolio in Q1 2026.
- Ameriprise opened 190 new positions and closed 216 in Q1 2026.
- Ameriprise's portfolio value fell 2.4% quarter-over-quarter to $432B.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.